LEAP India share price opened at ₹166 on the BSE, up 4.40 per cent over the issue price. Meanwhile, on the National Stock Exchange (NSE), it listed at a 4.34 per cent gain at ₹165.90.
LEAP India IPO GMP today is ₹13.5 apiece. This means shares of the company are trading at ₹172.5 in the unlisted market, suggesting a listing pop of nearly 8.5 per cent.
After shedding almost up to 5 per cent a day earlier, most Tata group stocks gained. Titan and Tata Investment Corporation remained the top laggards.
Four stocks, namely Trent, Nelco, Tata Investment Corporation and Titan Company, have seen a whopping 1,707 per cent to 1,018 per cent rise in almost 9.5 years.
Strong industry outlook, robust order book and customer base, along with scope for improved profitability, make analysts bullish on Behari Lal Engineering IPO.
DSP Mutual Fund said that despite their long-term earnings trajectory and current trailing valuations, there is room for SMIDs to underperform before they present broad investment opportunities.
Most of the group stocks traded with cuts of up to 4 per cent following the report. Crown jewel Tata Consultancy Services (TCS) was the top loser with a 4.12 per cent decline.
Swastika said Shiprocket IPO is best suited for high-risk, growth-oriented portfolios with a 2-3-year horizon rather than conservative value investors.
Sebi's annual report for financial year 2025-26 (FY26) shows that 198 schemes delivered 10 per cent-plus gains in the last fiscal year, as against 304 in FY25 and a whopping 822 in FY24.
Brooklyn-based US District Judge Nicholas Garaufis dismissed conspiracy, securities and wire fraud charges brought against them in a late-night order, marking an end to Adani's US legal troubles.
SBI Share: Analysts largely maintained bullish views on SBI shares following the Q1 results, foreseeing a 22 per cent upside from last closing price.
Emkay retained a 'Sell' call on Ola's stock with a target price of Rs 30 (down 26.8 per cent from last close) and opted to play the E-2W theme via Ather and TVS.
Molbio Diagnostics IPO: Molbio is a molecular diagnostic company that develops, manufactures, and commercializes point-of-care (POC) molecular diagnostic platforms.
Gaurang Shah of Geojit Financial Services said that Dabur has been in the market for a long time, has a good amount of goodwill for its products and an unmatched product portfolio.
Earlier today, Christopher Wood, global head of equity strategy at Jefferies, in his weekly note GREED & fear, revealed that he has exited HDFC Bank to make way for names like MCX and Lenksart.
This sustained FII buying has driven the BSE Capital Goods index 13 per cent in a year, and the BSE Metals pack 33 per cent against a near 3 per cent decline in the benchmark Sensex.
Sharp decline in Bajaj Finance shares also weighed on the BSE Financial Services pack, which lost 0.96 per cent in intraday deals.
From a broader perspective, we continue to see value in areas like software where valuations remain reasonable relative to long-term growth potential, says Rajat Chandak.
Retail investors often take cues from promoter buying, as it is a show of confidence by the company insiders.
Despite markets continuing to price in policy rate hikes over the next 6-12 months, the softer-than-expected tone of the policy has supported bond markets, said Deepak Agrawal, Kotak Mahindra AMC.